Francesco Mattia Uboldi

Dr. Francesco Mattia Uboldi

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2014 in The American Journal of Sports Medicine
Verified
Journal Article
Closed access
MBMassimo Berruto
Massimo Berruto
MDMarco Delcogliano
Marco Delcogliano
FCFrancesca de Caro
Francesca de Caro
GCGiulia Carimati
Giulia Carimati
FUFrancesco Mattia Uboldi
Francesco Mattia Uboldi
CBCarlo Felice De Biase
Carlo Felice De Biase
Background: Osteochondral knee lesions represent a challenging condition encountered by orthopaedic surgeons. A variety of methods have been developed to repair articular cartilage defects. However, these techniques are limited by donor site morbidity or by the requirement for a staged procedure. Purpose: To assess the effectiveness of a biomimetic osteochondral scaffold for the treatment of large osteochondral knee lesions. Study Design: Case series; Level of evidence, 4. Methods: From 2009 to 2011, a total of 49 patients affected by isolated large osteochondral knee lesions (mean [± SD] size, 4.35 ± 1.26 cm 2 ) were treated with the biomimetic scaffold. Patients were evaluated using the International Knee Documentation Committee (IKDC), Tegner, and visual analog scale (VAS) pain scores, as well as magnetic resonance imaging (MRI) up to 3-year follow-up. The MOCART (magnetic resonance observation of cartilage repair tissue) score was performed to analyze different variables. Biopsies were carried out in 5 patients. Four of the 5 second-look arthroscopies and biopsies were performed on patients with failed results because of ethical issues. Results: The mean IKDC subjective score increased significantly from 45.45 ± 19.29 preoperatively to 70.86 ± 18.08 at 1-year follow-up and to 75.42 ± 19.31 at 2-year follow-up ( P < .001). The IKDC objective score changed from 50% normal and nearly normal knees before treatment to 89.79% at the 2-year follow-up. There was a statistically significant improvement ( P < .005) in VAS score from the preoperative level (6.69 ± 1.88) to the 2-year follow-up (1.96 ± 2.47). Tegner scores increased ( P < .001) from the preoperative value (2.20 ± 0.67) to the 2-year follow-up (4.9 ± 1.73) without achieving preinjury level. A correlation was found between the IKDC subjective score and age ( P < .001, r = −0.497, ρ = −0.502). Patients affected by osteochondritis dissecans (OCD) achieved a statistically significantly better outcome ( P < .05). A subgroup of 19 competitive athletes showed a statistically significantly improvement ( P < .001) in the subjective IKDC (86.5 ± 13.2) compared with the nonathletic subpopulation (69.03 ± 19.41) at the 2-year follow-up. The MRI findings of 30 patients were available at 2-year follow-up: 70% showed complete filling of the lesion, 63.3% had an intact articular surface, and 86% had mild or no effusion. In all cases, in dual T2-weighted fast spin echo sequence, the repair tissue showed a hyperintensive signal with respect to the surrounding subchondral bone; however, no edema was observed. Conclusion: The study findings indicate that the biomimetic scaffold that was investigated is an off-the-shelf, cell-free, and cost-effective implant that can regenerate either cartilage or subchondral bone. The scaffold allows a 1-step surgical procedure that can be used for osteochondral lesions, OCD, and in some cases osteonecrosis.

8 February 2013 in Knee Surgery, Sports Traumatology, Arthroscopy
Verified
Journal Article
Closed access
PDF file
MBM. Berruto
M. Berruto
FUFrancesco Mattia Uboldi
Francesco Mattia Uboldi
LGL. Gala
L. Gala
BMB. Marelli
B. Marelli
WAW. Albisetti
W. Albisetti

5 April 2014 in Knee Surgery, Sports Traumatology, Arthroscopy
Verified
Journal Article
Closed access
PDF file
MBMassimo Berruto
Massimo Berruto
PFPaolo Ferrua
Paolo Ferrua
FUFrancesco Mattia Uboldi
Francesco Mattia Uboldi
EUEva Usellini
Eva Usellini
LGLuca Gala
Luca Gala
BMBruno Marelli
Bruno Marelli

13 February 2020 in Knee Surgery, Sports Traumatology, Arthroscopy
Verified
Journal Article
Closed access
PDF file
MBM. Berruto
M. Berruto
AMA. Maione
A. Maione
DTDaniele Tradati
Daniele Tradati
PFP. Ferrua
P. Ferrua
FUFrancesco Mattia Uboldi
Francesco Mattia Uboldi
EUE. Usellini
E. Usellini

1 December 2016 in The Knee
Verified
Journal Article
Closed access
MBM. Berruto
M. Berruto
PFP. Ferrua
P. Ferrua
FUFrancesco Mattia Uboldi
Francesco Mattia Uboldi
SPS. Pasqualotto
S. Pasqualotto
FFF. Ferrara
F. Ferrara
MDM. Delcogliano
M. Delcogliano

1 January 2021 in Journal of Experimental Orthopaedics
Verified
Journal Article
Open access
PDF file
MRMartina Ricci
Martina Ricci
DTDaniele Tradati
Daniele Tradati
AMAlessio Maione
Alessio Maione
FUFrancesco Mattia Uboldi
Francesco Mattia Uboldi
EUEva Usellini
Eva Usellini
MBMassimo Berruto
Massimo Berruto
Purpose: The treatment of osteochondral lesions is challenging and no consensus has been established about the best option for restoring both cartilage and subchondral bone. Multilayer collagen‐hydroxyapatite scaffolds have shown promising clinical results, but the outcome at a follow‐up longer than 5 years still has to be proved. The aim was to evaluate the clinical outcome of patients with a knee isolated osteochondral lesion treated with a biomimetic three‐layered scaffold at a minimum 5 years of follow‐up.Methods: Twenty‐nine patients (23 males and 6 females, mean age 31.5 ± 11.4 years) were evaluated retrospectively before surgery, at 1 and 2 years and at last follow‐up (FU). Visual Analog Scale (VAS) for pain, International Knee Documentation Committee (IKDC) Subjective Score, Tegner‐Lysholm Knee Scoring Scale and Tegner Activity Level Scale were collected. Mean FU was 7.8 ± 2.0 years (min 5.1 ‐ max 11.3). The etiology of the defect was Osteochondritis Dissecans or osteonecrosis (17 vs 12 cases).Results: At 12 months FU the IKDC score improved from 51.1 ± 21.7 to 80.1 ± 17.9 (p < 0.01), Tegner Lysholm Score from 59.9 ± 17.3 to 92.5 ± 9.0 (p < 0.01), VAS from 6.1 ± 2.1 to 1.7 ± 2.3 (p < 0.01) and Tegner Activity Level Scale from 1.6 ± 0.5 to 4.9 ± 1.7 (p < 0.01). The results remained stable at 24 months, while at last FU a statistically significant decrease in IKDC, Tegner Lysholm and Tegner Activity Scale was recorded, though not clinically relevant. Patients under 35 achieved statistically better outcomes.Conclusions: The use of a cell‐free collagen‐hydroxyapatite osteochondral scaffold provides substantial clinical benefits in the treatment of knee osteochondral lesions at a minimum follow‐up of 5 years, especially in patients younger than 35 years.Level of evidence: Level IV.